The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration

详细信息    查看全文

• 作者：Tobias M Nowacki ; Alan T Remaley ; Dominik Bettenworth ; Michel Eisenbltter ; Thorsten Vowinkel ; Felix Becker ; Thomas Vogl ; Johannes Roth ; Uwe J Tietge ; Andreas Lü ; gering ; Jan Heidemann and Jerzy-Roch Nofer
• 刊名：British Journal of Pharmacology
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：173
• 期：18
• 页码：2780-2792
• 全文大小：889K
• ISSN：1476-5381

文摘

New therapies for inflammatory bowel disease (IBD) are highly desirable. As apolipoprotein (apo)A-I mimetic peptides are beneficial in several animal models of inflammation, we hypothesized that they might be effective at inhibiting murine colitis.